- Breaking News Japan welcomes reelection of Karzai as Afghan president, vows support
- Breaking News U.S. editorial excerpts -2-
- Breaking News 3RD LD: Blast in Pakistan's Rawalpindi kills at least 30
- Breaking News Obama reaffirms support for Karzai as run-off is cancelled
Beacon Equity Research reports on the OTC and OTCBB Trade Leaders: Chemokine Therapeutics Corp. (OTCBB: CHKT), iVoice, Inc. (OTCBB: IVOI), Acro, Inc. (OTCBB: ACRI), Worldwide Manufacturing USA Inc. (OTCBB: WWMU), and CytoGenix, Inc. (OTCBB: CYGX) for January 09, 2008.
0 Comments | M2 Presswire, January, 2008
M2 PRESSWIRE-9 January 2008-BeaconEquityResearch.com: Beacon Equity Research reports on the OTC and OTCBB Trade Leaders: Chemokine Therapeutics Corp. (OTCBB: CHKT), iVoice, Inc. (OTCBB: IVOI), Acro, Inc. (OTCBB: ACRI), Worldwide Manufacturing USA Inc. (OTCBB: WWMU), and CytoGenix, Inc. (OTCBB: CYGX) for January 09, 2008.(C)1994-2008 M2 COMMUNICATIONS LTD
RDATE:09012008
To sign up for our free research reports and newsletters, visit http://beaconequityresearch.com/CHKT
January 08, 2008 - Chemokine Therapeutics Receives Approval From FDA to Commence Phase II Study
- Made from scratch: When Honda built a plant in Alabama it also built a workforce-using local workers who had no experience in making cars - Recruitment & Hiring
- Portfolio forecasting tools: what you need to know
- Empirically assessing the impact of BPR on banking firms
- Kemarie McMinn Named Executive Vice President of Halo Debt Solutions, Inc.
- Halo Debt Solutions, Inc. Supports Push Toward Industry Regulation
- Traction Named #1 Interactive Agency for 2009 by BtoB Magazine
- Halo Debt Solutions, Inc. Gives Debt Settlement a Face-Lift
- Banking technology, technological learning and competition: comparative case studies in Thai banking